Publication & Citation Trends
Publications
157 total
Brigatinib Versus Alectinib in ALK-positive Non-small Cell Lung Cancer After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial. OA
Cited by 38
Semantic Scholar
A first-in-human, open-label, dose escalation and expansion study of orally administered NX-019 in patients with advanced EGFR mutant cancer.
Cited by 1
Semantic Scholar
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors OA
Cited by 85
Semantic Scholar
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset OA
Cited by 6
Semantic Scholar
Management of patients with ALK-positive advanced non-small cell lung cancer who received brain radiotherapy on study in the phase 3 CROWN trial.
Cited by 0
Semantic Scholar
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy OA
Cited by 174
Semantic Scholar
Abstract 2166: Analysis of ctDNA next generation sequencing (NGS) for predicting response to amivantamab and lazertinib among patients with EGFR-mutant NSCLC after progression on osimertinib and platinum-based chemotherapy (CHRYSALIS-2 Cohort A)
Cited by 1
Semantic Scholar
NeoCOAST-2: A phase 2 study of neoadjuvant durvalumab plus novel immunotherapies (IO) and chemotherapy (CT) or MEDI5752 (volrustomig) plus CT, followed by surgery and adjuvant durvalumab plus novel IO or volrustomig alone in patients with resectable non-small-cell lung cancer (NSCLC).
Cited by 7
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(102)
Lung Cancer Research Studies
(60)
Lung Cancer Diagnosis and Treatment
(49)
Cancer Immunotherapy and Biomarkers
(31)
Colorectal Cancer Treatments and Studies
(12)
Affiliations
Karolinska University Hospital
Seoul National University
Hoseo University
The University of Melbourne
Chinese University of Hong Kong